188 related articles for article (PubMed ID: 27153197)
1. Deferred therapy is associated with improved overall survival in patients with newly diagnosed mantle cell lymphoma.
Cohen JB; Han X; Jemal A; Ward EM; Flowers CR
Cancer; 2016 Aug; 122(15):2356-63. PubMed ID: 27153197
[TBL] [Abstract][Full Text] [Related]
2. Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network.
Hoster E; Klapper W; Hermine O; Kluin-Nelemans HC; Walewski J; van Hoof A; Trneny M; Geisler CH; Di Raimondo F; Szymczyk M; Stilgenbauer S; Thieblemont C; Hallek M; Forstpointner R; Pott C; Ribrag V; Doorduijn J; Hiddemann W; Dreyling MH; Unterhalt M
J Clin Oncol; 2014 May; 32(13):1338-46. PubMed ID: 24687837
[TBL] [Abstract][Full Text] [Related]
3. Deferred treatment is a safe and viable option for selected patients with mantle cell lymphoma.
Calzada O; Switchenko JM; Maly JJ; Blum KA; Grover N; Mathews S; Park SI; Gordon M; Danilov A; Epperla N; Fenske TS; Hamadani M; Flowers CR; Cohen JB
Leuk Lymphoma; 2018 Dec; 59(12):2862-2870. PubMed ID: 29912594
[TBL] [Abstract][Full Text] [Related]
4. Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2012 Jun; 87(6):604-9. PubMed ID: 22615102
[TBL] [Abstract][Full Text] [Related]
5. Intensive induction regimens after deferring initial therapy for mantle cell lymphoma are not associated with improved survival.
Shanmugasundaram K; Goyal S; Switchenko J; Calzada O; Churnetski MC; Kolla B; Bachanova V; Gerson JN; Barta SK; Gordon MJ; Danilov AV; Grover NS; Mathews S; Burkart M; Karmali R; Sawalha Y; Hill BT; Ghosh N; Park SI; Epperla N; Bond DA; Badar T; Blum KA; Hamadani M; Fenske TS; Malecek M; Kahl BS; Martin P; Guo J; Flowers CR; Cohen JB
Eur J Haematol; 2021 Sep; 107(3):301-310. PubMed ID: 33973276
[TBL] [Abstract][Full Text] [Related]
6. Management Trends and Outcomes for Stage I to II Mantle Cell Lymphoma Using the National Cancer Data Base: Ascertaining the Ideal Treatment Paradigm.
Gill BS; Vargo JA; Pai SS; Balasubramani GK; Beriwal S
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):668-76. PubMed ID: 26461009
[TBL] [Abstract][Full Text] [Related]
7. Extranodal Head and Neck Mantle Cell Lymphoma: Characteristics, Treatment, and Survival.
Breen CT; Chao J; Mehra S; Kohli N
Ann Otol Rhinol Laryngol; 2022 Apr; 131(4):412-419. PubMed ID: 34137303
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network.
Hoster E; Rosenwald A; Berger F; Bernd HW; Hartmann S; Loddenkemper C; Barth TF; Brousse N; Pileri S; Rymkiewicz G; Kodet R; Stilgenbauer S; Forstpointner R; Thieblemont C; Hallek M; Coiffier B; Vehling-Kaiser U; Bouabdallah R; Kanz L; Pfreundschuh M; Schmidt C; Ribrag V; Hiddemann W; Unterhalt M; Kluin-Nelemans JC; Hermine O; Dreyling MH; Klapper W
J Clin Oncol; 2016 Apr; 34(12):1386-94. PubMed ID: 26926679
[TBL] [Abstract][Full Text] [Related]
9. TCL1 expression predicts overall survival in patients with mantle cell lymphoma.
Shin SJ; Roh J; Cha HJ; Choi YD; Kim JM; Min SK; Kim JE; Eom DW; Lee H; Kim HJ; Yoon DH; Suh C; Huh J
Eur J Haematol; 2015 Dec; 95(6):583-94. PubMed ID: 25688912
[TBL] [Abstract][Full Text] [Related]
10. Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype.
Bernard M; Gressin R; Lefrère F; Drénou B; Branger B; Caulet-Maugendre S; Tass P; Brousse N; Valensi F; Milpied N; Voilat L; Sadoun A; Ghandour C; Hunault M; Leloup R; Mannone L; Hermine O; Lamy T
Leukemia; 2001 Nov; 15(11):1785-91. PubMed ID: 11681422
[TBL] [Abstract][Full Text] [Related]
11. Racial and Socioeconomic Disparities in Mantle Cell Lymphoma.
Shah NN; Xi Y; Liu Y; Koff JL; Flowers CR; Behera M; Cohen JB
Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):e312-e320. PubMed ID: 31029647
[TBL] [Abstract][Full Text] [Related]
12. The REFRACT-LYMA cohort study: a French observational prospective cohort study of patients with mantle cell lymphoma.
Hanf M; Chiron D; de Visme S; Touzeau C; Maisonneuve H; Jardel H; Pellat-Deceunynck C; Amiot M; le Gouill S
BMC Cancer; 2016 Oct; 16(1):802. PubMed ID: 27737650
[TBL] [Abstract][Full Text] [Related]
13. Association of red blood cell distribution width and outcomes in patients with mantle cell lymphoma.
Miao Y; Zhou XH; Guo JJ; Sun Q; Shi K; Wu JZ; Zhu HY; Wang L; Fan L; Xu W; Li JY
Cancer Med; 2019 Jun; 8(6):2751-2758. PubMed ID: 30980510
[TBL] [Abstract][Full Text] [Related]
14. Low absolute NK cell counts in peripheral blood are associated with inferior survival in patients with mantle cell lymphoma.
Zhou XH; Zhang XY; Liang JH; Zhu HY; Wang L; Xia Y; Cao L; Wu W; Fan L; Li JY; Xu W
Cancer Biomark; 2019; 24(4):439-447. PubMed ID: 30932881
[TBL] [Abstract][Full Text] [Related]
15. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091
[TBL] [Abstract][Full Text] [Related]
16. Effect of radiotherapy on the survival of patients with stage I and stage II mantle cell lymphoma: analysis of the Surveillance, Epidemiology and End Results database.
Guru Murthy GS; Venkitachalam R; Mehta P
Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl():S90-5. PubMed ID: 25486963
[TBL] [Abstract][Full Text] [Related]
17. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436
[TBL] [Abstract][Full Text] [Related]
18. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
Rasmussen PK
Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome for patients with early stage marginal zone lymphoma and mantle cell lymphoma.
Barzenje DA; Holte H; Fosså A; Ghanima W; Liestøl K; Delabie J; Kolstad A
Leuk Lymphoma; 2017 Mar; 58(3):623-632. PubMed ID: 27389974
[TBL] [Abstract][Full Text] [Related]
20. Absolute monocyte count predicts overall survival in mantle cell lymphomas: correlation with tumour-associated macrophages.
Koh YW; Shin SJ; Park C; Yoon DH; Suh C; Huh J
Hematol Oncol; 2014 Dec; 32(4):178-86. PubMed ID: 24910369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
